ConductScience.org, home

Paper41518477

The role of bacteriophages and CRISPR-Cas in combating multidrug-resistant bacteria.

Ghazaei C. Nat Prod Bioprospect, 2026. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. The role of bacteriophages and CRISPR-Cas in combating multidrug-resistant bacteria. Papers, record 41518477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41518477

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The role of bacteriophages and CRISPR-Cas in combating multidrug-resistant bacteria.
PubMed
Journal
Nat Prod Bioprospect
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-01-13
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ghazaei CCiamak

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References72

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125240928Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases.Nat Biotechnol2014https://conductscience.org/library/papers/25240928PubMed
240872511Combating Antimicrobial Resistance: Innovative Strategies Using Peptides, Nanotechnology, Phages, Quorum Sensing Interference, and CRISPR-Cas Systems.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40872511PubMed
334812714Machine learning for identifying resistance features of Klebsiella pneumoniae using whole-genome sequence single nucleotide polymorphisms.J Med Microbiol2021https://conductscience.org/library/papers/34812714PubMed
426628643Rationally engineered Cas9 nucleases with improved specificity.Science2016https://conductscience.org/library/papers/26628643PubMed
525282355Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.Nat Biotechnol2014https://conductscience.org/library/papers/25282355PubMed
631756187CRISPR-Cas9 modified bacteriophage for treatment of Staphylococcus aureus induced osteomyelitis and soft tissue infection.PLoS One2019https://conductscience.org/library/papers/31756187PubMed
722558257CRISPR interference directs strand specific spacer acquisition.PLoS One2012https://conductscience.org/library/papers/22558257PubMed
833346710Evaluation of Homology-Independent CRISPR-Cas9 Off-Target Assessment Methods.CRISPR J2020https://conductscience.org/library/papers/33346710PubMed
940836971Strategies and delivery systems for cell-based therapy in autoimmunity.Front Drug Deliv2024https://conductscience.org/library/papers/40836971PubMed
1031942051The arms race between bacteria and their phage foes.Nature2020https://conductscience.org/library/papers/31942051PubMed
1134480904Focused review on dual inhibition of quorum sensing and efflux pumps: A potential way to combat multi drug resistant Staphylococcus aureus infections.Int J Biol Macromol2021https://conductscience.org/library/papers/34480904PubMed
1230724156Mechanisms of Type I-E and I-F CRISPR-Cas Systems in Enterobacteriaceae.EcoSal Plus2019https://conductscience.org/library/papers/30724156PubMed
1335972246Engineered Bacteriophages Containing Anti-CRISPR Suppress Infection of Antibiotic-Resistant P. aeruginosa.Microbiol Spectr2022https://conductscience.org/library/papers/35972246PubMed
1434917066Uses of Bacteriophages as Bacterial Control Tools and Environmental Safety Indicators.Front Microbiol2021https://conductscience.org/library/papers/34917066PubMed
1515964098Bacterial resistance to antibiotics: modified target sites.Adv Drug Deliv Rev2005https://conductscience.org/library/papers/15964098PubMed
1639355200Phage therapy: A novel approach against multidrug-resistant pathogens.3 Biotech2024https://conductscience.org/library/papers/39355200PubMed
1735065702Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.Lancet2022https://conductscience.org/library/papers/35065702PubMed
1839170521Genetically engineered phages and engineered phage-derived enzymes to destroy biofilms of antibiotics resistance bacteria.Heliyon2024https://conductscience.org/library/papers/39170521PubMed
1934597746Enzymatically releasable polyethylene glycol - host defense peptide conjugates with improved activity and biocompatibility.J Control Release2021https://conductscience.org/library/papers/34597746PubMed
2033803604Promising Drug Candidates and New Strategies for Fighting against the Emerging Superbug Candida auris.Microorganisms2021https://conductscience.org/library/papers/33803604PubMed

See all 72 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42792542Mapping Bacteriophage-Based Antimicrobial Research in Southeast Asia: A Bibliometric Analysis of Scientific Productivity, Knowledge Structure, and Emerging Research Pathways.Biology (Basel)2026https://conductscience.org/library/papers/42792542PubMed
42357332Phenotype-Guided Nanotherapeutic Strategies for Carbapenem-Resistant Acinetobacter baumannii: Toward Precision Antimicrobial Intervention.Pharmaceutics2026https://conductscience.org/library/papers/42357332PubMed
42325637Advancements in Technologies Targeting Horizontal Gene TransferRoutes to Control Drug Resistance Evolution.ACS Bio Med Chem Au2026https://conductscience.org/library/papers/42325637PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41518477

GET https://conductscience.org/api/papers/v1/41518477/references?page=2